3CLpro inhibitors: DEL-based molecular generation.
Xiong F, Xu H, Yu M, Chen X, Zhong Z, Guo Y, Chen M, Ou H, Wu J, Xie A, Xiong J, Xu L, Zhang L, Zhong Q, Huang L, Li Z, Zhang T, Jin F, He X.
Xiong F, et al. Among authors: xiong j.
Front Pharmacol. 2022 Dec 7;13:1085665. doi: 10.3389/fphar.2022.1085665. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36569316
Free PMC article.